HypertensionCardiovascular Events During Differing Hypertension Therapies in Patients With Diabetes
Key Words
Abbreviations and Acronyms
Cited by (0)
This study was supported financially by Novartis, who also provided logistical and statistical support and expertise (based on the analysis plans of the academic authors). Dr. Weber receives lecture fees from Boehringer Ingelheim, Bristol-Myers Squibb, Daiichi Sankyo, Forest Pharmaceuticals, GlaxoSmithKline, Novartis, and Sanofi-Aventis; and consultant fees from Boehringer Ingelheim, Bristol-Myers Squibb, Daiichi Sankyo, Forest Pharmaceuticals, GlaxoSmithKline, Gilead, Novartis, and Takeda Pharmaceuticals. Dr. Bakris receives consulting fees from Merck, Takeda, Boehringer-Ingelheim, Abbott Laboratories, Walgreen's, BMS/Sanofi, Gilead, Novartis, Forest Pharmaceuticals, GlaxoSmithKline, and Daiichi Sankyo; lecture fees from Novartis and Forest Pharmaceuticals; and grant support from GlaxoSmithKline, Juvenile Diabetes Research Foundation, Forest Labs, and CVRx. Dr. Jamerson receives consulting fees from Novartis, Merck, and Daiichi Sankyo; lecture fees from Novartis, Abbott Laboratories, Bristol-Myers Squibb, GlaxoSmithKline, and Merck; and research support from NIH, NIDDK, NHLBI, Novartis, and King Pharmaceuticals. Dr. Weir serves as scientific advisor for Amgen, Nicox, Novartis, Boehringer Ingelheim, Sanofi, Bristol-Myers Squibb, Daiichi Sankyo, and Johnson & Johnson. Dr. Kjeldsen receives lecture fees from Novartis, AstraZeneca, Bayer, Boehringer-Ingelheim, Menarini, Merck, Sankyo, Sanofi, Servier, and Takeda. Dr. Devereux serves on an advisory board for Merck and has received lecture fees from Merck within the past 2 years; during the same time period, he has served as a consultant for Novartis, Sanofi-Aventis, Novo Nordisk Pharmaceuticals, and Neurosearch. Dr. Velazquez receives consulting and lecture fees from Novartis, Cardio-Kinetix, NovaCardia, and Medtronic Foundation. Dr. Dahlöf receives consulting fees from Novartis, Daiichi Sankyo, and Boehringer Ingelheim and lecture fees from Novartis, Boehringer Ingelheim, Pfizer, and Merck. Roxzana Kelly, Tsushung Hua, and Allen Hester are employed by Novartis Pharmaceuticals. Dr. Pitt receives consulting fees from Novartis, Pfizer, Merck, Takeda, Bayer, Forest Laboratories, Sankyo, Ono, and AstraZeneca; has stock options from Relypsa, BG-Medicine, and Nile Therapeutics; and has received grants from Medtronic, Bayer, Novartis, and Abbott Laboratories.